Vor Biopharma VOR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$2.45B-47.2% | -$1.66B-1,303% | -$118.6M-1.4% | ||
| $2.15M-27.0% | $2.95M-22.2% | $3.79M-19.1% | $4.69M+34.4% | $3.49M-3.3% | ||
| $25.85M+36.7% | $18.91M+39.9% | $13.52M+74.4% | $7.75M-10.9% | $8.7M-11.7% | ||
| -$149.89M-5.0% | -$142.71M+0.9% | -$143.98M-26.7% | -$113.6M-13.3% | -$100.26M-0.6% | ||
| $758K-19.4% | $941K+34.6% | $699K+42.9% | $489K+41.3% | $346K+51.1% | ||
| -$311.81M-539% | -$48.8M— | —— | —— | —— | ||
| $579.28M+15.0% | $503.81M+102% | $249.29M+9.4% | $227.79M+332% | $52.72M-1.3% | ||
| —— | —— | —— | —— | —— | ||
| -$150.65M-4.9% | -$143.65M+0.7% | -$144.67M-26.8% | -$114.09M-13.4% | -$100.61M-0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vor Biopharma generate?
- Vor Biopharma (VOR) generated -$149.9M in operating cash flow over the trailing twelve months.
- What is Vor Biopharma's free cash flow?
- After $758.0K of capital expenditures, Vor Biopharma's free cash flow was -$150.7M over the trailing twelve months, down 49.7% year over year.
- Where does Vor Biopharma's cash flow data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.